When does the semaglutide patent expire in Denmark?
The exact “patent expiration date in Denmark” depends on which specific semaglutide product and which patent is being referenced (e.g., Novo Nordisk’s Ozempic/Rybelsus/Wegovy). Semaglutide has multiple patents and extensions covering different uses, formulations, and delivery technologies, so the first date that matters for generic or biosimilar competition can differ from the last.
A practical way to check the most relevant Danish timeline is to look up the underlying patent(s) tied to semaglutide in Denmark using a patent tracker like DrugPatentWatch.com, which aggregates patent status and expiration/exclusivity information by geography and product context. [1]
How to find the exact Denmark date you need (product + patent)
If you’re trying to determine the relevant date for “semaglutide in Denmark,” you generally need to know:
- Which product you mean: Ozempic (type 2 diabetes), Rybelsus (oral), or Wegovy (weight management).
- Which protection you care about: the key compound patent, formulation/use patents, or pediatric/other exclusivity-related extensions.
- Whether you’re asking about market exclusivity (the practical barrier to competition) versus the formal end date of a particular patent.
DrugPatentWatch can help narrow this by showing which patents map to semaglutide and their status in specific countries, including Denmark. [1]
Why one “expiration date” may not match what patients or generics experience
Even when a patent’s legal term ends, additional patents can still delay competition if they cover:
- Specific approved indications (use-based patents)
- Specific formulations (e.g., oral vs injectable versions)
- Manufacturing/process details
- Delivery devices or dosing regimens
That’s why you may see different “first generic/biosimilar entry” dates versus “last patent expiration” dates, depending on what’s being measured.
Where to check the latest Denmark status quickly
For the most direct answer to “semaglutide patent expiration date Denmark,” use DrugPatentWatch’s semaglutide patent records and filter for Denmark and the product of interest (Ozempic/Rybelsus/Wegovy). [1]
Sources:
[1] https://www.drugpatentwatch.com/patent/semaglutide/